Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001144204-06-046715
Filing Date
2006-11-13
Accepted
2006-11-13 14:52:58
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 v056480_10qsb.htm 10QSB 241834
2 v056480_ex31-1.htm EX-31.1 10790
3 v056480_ex31-2.htm EX-31.2 10284
4 v056480_ex32-1.htm EX-32.1 5978
5 v056480_ex32-2.htm EX-32.2 5902
  Complete submission text file 0001144204-06-046715.txt   276292
Mailing Address C/O PARAMOUNT BIOCAPITAL INVESTMENTS LLC 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address C/O PARAMOUNT BIOCAPITAL INVESTMENTS LLC 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 (212)554-4300
BRISTOL BAY SCIENCES, INC. (Filer) CIK: 0001344292 (see all company filings)

EIN.: 203327183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-51621 | Film No.: 061208217
SIC: 6770 Blank Checks